Artículos

The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis / Shubulade Smith en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 109-114 Título : The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis Tipo de documento: texto impreso Autores: Shubulade Smith, Autor ; Michael J. Wheeler, Autor ; Robin M. Murray, Autor Fecha de publicación: 2023 Artículo en la página: pp. 109-114 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Hormonas esteroides gonadales, Hiperprolactinemia, Hipogonadismo, Prolactina, Esquizofrenia. Resumen: Hyperprolactinaemia is commonly induced by antipsychotic medications that have dopamine-blockade as their main mechanism of action. The purpose of this study was to assess the effect of antipsychotic-induced hyperprolactinaemia on hypothalamic-pituitary-gonadal axis (HPG) function. Link: ./index.php?lvl=notice_display&id=31074 [artículo] The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis [texto impreso] / Shubulade Smith, Autor ; Michael J. Wheeler, Autor ; Robin M. Murray, Autor . - 2023 . - pp. 109-114. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 109-114 Palabras clave: Antipsicóticos, Hormonas esteroides gonadales, Hiperprolactinemia, Hipogonadismo, Prolactina, Esquizofrenia. Resumen: Hyperprolactinaemia is commonly induced by antipsychotic medications that have dopamine-blockade as their main mechanism of action. The purpose of this study was to assess the effect of antipsychotic-induced hyperprolactinaemia on hypothalamic-pituitary-gonadal axis (HPG) function. Link: ./index.php?lvl=notice_display&id=31074

Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study / Yoram Barak en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 115-120 Título : Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study Tipo de documento: texto impreso Autores: Yoram Barak, Autor ; Eyal Shamir, Autor ; Ronit Weizman, Autor Fecha de publicación: 2023 Artículo en la página: pp. 115-120 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Enfermedad crónica, Trastornos psicóticos, Risperidona, Esquizofrenia. Resumen: Elderly chronic schizophrenia patients are particularly difficult to treat because of aging-related changes, cognitive impairment, and comorbid physical illness. This article describes a naturalistic, retrospective study of typical antipsychotic treatment versus risperidone for elderly psychotic inpatients. Link: ./index.php?lvl=notice_display&id=31075 [artículo] Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study [texto impreso] / Yoram Barak, Autor ; Eyal Shamir, Autor ; Ronit Weizman, Autor . - 2023 . - pp. 115-120. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 115-120 Palabras clave: Antipsicóticos, Enfermedad crónica, Trastornos psicóticos, Risperidona, Esquizofrenia. Resumen: Elderly chronic schizophrenia patients are particularly difficult to treat because of aging-related changes, cognitive impairment, and comorbid physical illness. This article describes a naturalistic, retrospective study of typical antipsychotic treatment versus risperidone for elderly psychotic inpatients. Link: ./index.php?lvl=notice_display&id=31075

The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine / Steven G. Potkin en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 121-130 Título : The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine Tipo de documento: texto impreso Autores: Steven G. Potkin, Autor ; Per T. Thyrum, Autor ; Gustavo Alva, Autor Fecha de publicación: 2023 Artículo en la página: pp. 121-130 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Trastorno bipolar, Dibenzotiazepinas, Terapia medicamentosa, Haloperidol, Trastornos psicóticos, Risperidona, Esquizofrenia. Resumen: The effects of haloperidol, risperidone, and thioridazine on the pharmacokinetics and side-effect profile of quetiapine were investigated in 36 patients with schizophrenia, schizoaffective disorder, or bipolar disorder in a single-center, two-period, multiple-dose, open-label, randomized trial. Link: ./index.php?lvl=notice_display&id=31076 [artículo] The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine [texto impreso] / Steven G. Potkin, Autor ; Per T. Thyrum, Autor ; Gustavo Alva, Autor . - 2023 . - pp. 121-130. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 121-130 Palabras clave: Antipsicóticos, Trastorno bipolar, Dibenzotiazepinas, Terapia medicamentosa, Haloperidol, Trastornos psicóticos, Risperidona, Esquizofrenia. Resumen: The effects of haloperidol, risperidone, and thioridazine on the pharmacokinetics and side-effect profile of quetiapine were investigated in 36 patients with schizophrenia, schizoaffective disorder, or bipolar disorder in a single-center, two-period, multiple-dose, open-label, randomized trial. Link: ./index.php?lvl=notice_display&id=31076

Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients / Arianna De Lalla ; Alessandro Leo en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 131-136 Título : Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients Tipo de documento: texto impreso Autores: Arianna De Lalla, Autor ; Alessandro Leo, Autor Fecha de publicación: 2023 Artículo en la página: pp. 131-136 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Fluoxetina, Serotonina. Resumen: Depression is a mood disorder characterized by complex alterations of neurotransmitters such as serotonin, norepinephrine, and dopamine. In particular, there is substantial evidence of abnormalities in serotonin neurotransmission. Peripheral parameters of serotoninergic transmission, such as the 5-hydroxytryptamine content of plasma and platelets, have been used to identify biochemical alterations related to depression. Link: ./index.php?lvl=notice_display&id=31077 [artículo] Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients [texto impreso] / Arianna De Lalla, Autor ; Alessandro Leo, Autor . - 2023 . - pp. 131-136. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 131-136 Palabras clave: Trastorno depresivo mayor, Fluoxetina, Serotonina. Resumen: Depression is a mood disorder characterized by complex alterations of neurotransmitters such as serotonin, norepinephrine, and dopamine. In particular, there is substantial evidence of abnormalities in serotonin neurotransmission. Peripheral parameters of serotoninergic transmission, such as the 5-hydroxytryptamine content of plasma and platelets, have been used to identify biochemical alterations related to depression. Link: ./index.php?lvl=notice_display&id=31077

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia / Maurizio Fava en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 137-147 Título : Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia Tipo de documento: texto impreso Autores: Maurizio Fava, Autor ; Sharon L. Hoog, Autor ; Rajinder A. Judge, Autor Fecha de publicación: 2023 Artículo en la página: pp. 137-147 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno Depresivo Mayor, Fluoxetina, Paroxetina, Sertralina, Trastornos del sueño. Resumen: This study assessed whether fluoxetine, sertraline, and paroxetine differ in efficacy and tolerability in depressed patients and the impact of baseline insomnia on outcomes. Patients (N = 284) with DSM-IV major depressive disorder were randomly assigned in a double-blind fashion to fluoxetine, paroxetine, or sertraline for 10 to 16 weeks of treatment. Link: ./index.php?lvl=notice_display&id=31078 [artículo] Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia [texto impreso] / Maurizio Fava, Autor ; Sharon L. Hoog, Autor ; Rajinder A. Judge, Autor . - 2023 . - pp. 137-147. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 137-147 Palabras clave: Antidepresivos, Trastorno Depresivo Mayor, Fluoxetina, Paroxetina, Sertralina, Trastornos del sueño. Resumen: This study assessed whether fluoxetine, sertraline, and paroxetine differ in efficacy and tolerability in depressed patients and the impact of baseline insomnia on outcomes. Patients (N = 284) with DSM-IV major depressive disorder were randomly assigned in a double-blind fashion to fluoxetine, paroxetine, or sertraline for 10 to 16 weeks of treatment. Link: ./index.php?lvl=notice_display&id=31078

Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study / Richard Bergeron en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 148-154 Título : Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study Tipo de documento: texto impreso Autores: Richard Bergeron, Autor ; Arun V. Ravindran, Autor ; Yves Chaput, Autor Fecha de publicación: 2023 Artículo en la página: pp. 148-154 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Fluoxetina, Trastorno Obsesivo-Compulsivo, Inhibidores selectivos de la recaptación de serotonina, Sertralina. Resumen: The purpose of this study was to evaluate the comparative efficacy and tolerability of sertraline and fluoxetine in the treatment of obsessivecompulsive disorder (OCD). Outpatients meeting DSM-IV criteria for OCD, with a Yale-Brown Obsessive-Compulsive (Y-BOCS) total score ≥ 17, an NIMH Global Obsessive-Compulsive (NIMH-OC) scale score ≥ 7, and a CGI-Severity score ≥ 4 were randomized to 24 weeks of double-blind treatment with sertraline (N = 77) or fluoxetine (N = 73). Link: ./index.php?lvl=notice_display&id=31079 [artículo] Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study [texto impreso] / Richard Bergeron, Autor ; Arun V. Ravindran, Autor ; Yves Chaput, Autor . - 2023 . - pp. 148-154. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 148-154 Palabras clave: Fluoxetina, Trastorno Obsesivo-Compulsivo, Inhibidores selectivos de la recaptación de serotonina, Sertralina. Resumen: The purpose of this study was to evaluate the comparative efficacy and tolerability of sertraline and fluoxetine in the treatment of obsessivecompulsive disorder (OCD). Outpatients meeting DSM-IV criteria for OCD, with a Yale-Brown Obsessive-Compulsive (Y-BOCS) total score ≥ 17, an NIMH Global Obsessive-Compulsive (NIMH-OC) scale score ≥ 7, and a CGI-Severity score ≥ 4 were randomized to 24 weeks of double-blind treatment with sertraline (N = 77) or fluoxetine (N = 73). Link: ./index.php?lvl=notice_display&id=31079

Specific side effects of long-term imipramine management of panic disorder / Matig Mavissakalian en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 155-161 Título : Specific side effects of long-term imipramine management of panic disorder Tipo de documento: texto impreso Autores: Matig Mavissakalian, Autor ; James Perel, Autor ; Shenyang Guo, Autor Fecha de publicación: 2023 Artículo en la página: pp. 155-161 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agorafobia, Excitación, Imipramina, Cuidado a largo plazo, Trastorno de pánico. Resumen: In a recent study, the authors suggested that tachycardia, dry mouth, and sweating continued to burden patients with panic disorder with agoraphobia who have shown marked and stable response to 6 months of imipramine treatment at the fixed, weight-adjusted dose of 2.25 mg/kg/day. Link: ./index.php?lvl=notice_display&id=31080 [artículo] Specific side effects of long-term imipramine management of panic disorder [texto impreso] / Matig Mavissakalian, Autor ; James Perel, Autor ; Shenyang Guo, Autor . - 2023 . - pp. 155-161. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 155-161 Palabras clave: Agorafobia, Excitación, Imipramina, Cuidado a largo plazo, Trastorno de pánico. Resumen: In a recent study, the authors suggested that tachycardia, dry mouth, and sweating continued to burden patients with panic disorder with agoraphobia who have shown marked and stable response to 6 months of imipramine treatment at the fixed, weight-adjusted dose of 2.25 mg/kg/day. Link: ./index.php?lvl=notice_display&id=31080

In vitro inhibition of pimozide n-dealkylation by selective serotonin reuptake inhibitors and azithromycin / Zeruesenay Desta en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 162-168 Título : In vitro inhibition of pimozide n-dealkylation by selective serotonin reuptake inhibitors and azithromycin Tipo de documento: texto impreso Autores: Zeruesenay Desta, Autor ; Nadia Soukhova, Autor ; David A. Flockhart, Autor Fecha de publicación: 2023 Artículo en la página: pp. 162-168 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Azitromicina, Inhibidores de la enzima citocromo P-450, Técnicas In Vitro, Microsomas, Oxidorreductasas. Resumen: Pimozide is often coprescribed with serotonin reuptake inhibitor (SSRI) antidepressants to treat depression in patients with Tourette’s syndrome. In human liver microsomes (HLMs), the inhibition of the primary route of pimozide metabolism, N-dealkylation to 1,3-dihydro-1-(4–piperidinyl)-2H-benzimidazol-2-one (DHPBI), by four SSRIs (fluoxetine, sertraline, paroxetine, and fluvoxamine) and azithromycin was tested. Link: ./index.php?lvl=notice_display&id=31081 [artículo] In vitro inhibition of pimozide n-dealkylation by selective serotonin reuptake inhibitors and azithromycin [texto impreso] / Zeruesenay Desta, Autor ; Nadia Soukhova, Autor ; David A. Flockhart, Autor . - 2023 . - pp. 162-168. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 162-168 Palabras clave: Azitromicina, Inhibidores de la enzima citocromo P-450, Técnicas In Vitro, Microsomas, Oxidorreductasas. Resumen: Pimozide is often coprescribed with serotonin reuptake inhibitor (SSRI) antidepressants to treat depression in patients with Tourette’s syndrome. In human liver microsomes (HLMs), the inhibition of the primary route of pimozide metabolism, N-dealkylation to 1,3-dihydro-1-(4–piperidinyl)-2H-benzimidazol-2-one (DHPBI), by four SSRIs (fluoxetine, sertraline, paroxetine, and fluvoxamine) and azithromycin was tested. Link: ./index.php?lvl=notice_display&id=31081

Differential time course of cytochrome p450 2d6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers / Heidi L. Liston en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 169-173 Título : Differential time course of cytochrome p450 2d6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers Tipo de documento: texto impreso Autores: Heidi L. Liston, Autor ; C. Lindsay DeVane, Autor ; David W. Boulton, Autor Fecha de publicación: 2023 Artículo en la página: pp. 169-173 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Inhibidores del citocromo P-450 CYP2D6, Fluoxetina, Paroxetina, Inhibidores selectivos de la recaptación de serotonina, Sertralina, Síndrome de abstinencia de sustancias. Resumen: The selective serotonin reuptake inhibitors (SSRIs) paroxetine, sertraline, and fluoxetine have varying degrees of potency in inhibiting the hepatic cytochrome P450 (CYP) 2D6 enzyme. However, the time course for maximum inhibition to occur or for inhibition to dissipate when dosing is discontinued, requires clarification. In an open label, parallel group study of 45 healthy volunteers, the time course of CYP2D6 inhibition of the above SSRIs was evaluated. Link: ./index.php?lvl=notice_display&id=31082 [artículo] Differential time course of cytochrome p450 2d6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers [texto impreso] / Heidi L. Liston, Autor ; C. Lindsay DeVane, Autor ; David W. Boulton, Autor . - 2023 . - pp. 169-173. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 169-173 Palabras clave: Inhibidores del citocromo P-450 CYP2D6, Fluoxetina, Paroxetina, Inhibidores selectivos de la recaptación de serotonina, Sertralina, Síndrome de abstinencia de sustancias. Resumen: The selective serotonin reuptake inhibitors (SSRIs) paroxetine, sertraline, and fluoxetine have varying degrees of potency in inhibiting the hepatic cytochrome P450 (CYP) 2D6 enzyme. However, the time course for maximum inhibition to occur or for inhibition to dissipate when dosing is discontinued, requires clarification. In an open label, parallel group study of 45 healthy volunteers, the time course of CYP2D6 inhibition of the above SSRIs was evaluated. Link: ./index.php?lvl=notice_display&id=31082

Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine / Steven G. Potkin en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 174-182 Título : Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine Tipo de documento: texto impreso Autores: Steven G. Potkin, Autor ; Per T. Thyrum, Autor ; Gustavo Alva, Autor Fecha de publicación: 2023 Artículo en la página: pp. 174-182 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Trastorno bipolar, Dibenzotiacepinas, Interacción medicamentosa, Fluoxetina, Imipramina, Trastornos psicóticos, Esquizofrenia. Resumen: The effects of fluoxetine and imipramine on the pharmacokinetics and nonpsychiatric side effect profile of quetiapine fumarate were investigated in 26 patients with schizophrenia, schizoaffective disorder, or bipolar disorder in a multicenter, twoperiod, multiple-dose, open-label, randomized trial. Link: ./index.php?lvl=notice_display&id=31083 [artículo] Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine [texto impreso] / Steven G. Potkin, Autor ; Per T. Thyrum, Autor ; Gustavo Alva, Autor . - 2023 . - pp. 174-182. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 174-182 Palabras clave: Antipsicóticos, Trastorno bipolar, Dibenzotiacepinas, Interacción medicamentosa, Fluoxetina, Imipramina, Trastornos psicóticos, Esquizofrenia. Resumen: The effects of fluoxetine and imipramine on the pharmacokinetics and nonpsychiatric side effect profile of quetiapine fumarate were investigated in 26 patients with schizophrenia, schizoaffective disorder, or bipolar disorder in a multicenter, twoperiod, multiple-dose, open-label, randomized trial. Link: ./index.php?lvl=notice_display&id=31083

Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers / Harm J. Gijsman en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 183-189 Título : Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers Tipo de documento: texto impreso Autores: Harm J. Gijsman, Autor ; Joop M. A. van Gerven, Autor ; Marieke L. de Kam, Autor Fecha de publicación: 2023 Artículo en la página: pp. 183-189 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Carbidopa, Hidrocortisona, Receptores presinápticos, Serotonina. Resumen: Single-dose administration of 5-hydroxytryptophan (5-HTP) is regularly used as a challenge test of the serotonergic system. The use of 5-HTP has been limited by an apparent small window between the occurrence of neuroendocrine endpoints and the occurrence of side effects. Therefore, many dosing strategies have been tried with and without concurrent administration of carbidopa, a peripheral inhibitor of the decarboxylation from 5-HTP to serotonin. Link: ./index.php?lvl=notice_display&id=31084 [artículo] Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers [texto impreso] / Harm J. Gijsman, Autor ; Joop M. A. van Gerven, Autor ; Marieke L. de Kam, Autor . - 2023 . - pp. 183-189. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 183-189 Palabras clave: Carbidopa, Hidrocortisona, Receptores presinápticos, Serotonina. Resumen: Single-dose administration of 5-hydroxytryptophan (5-HTP) is regularly used as a challenge test of the serotonergic system. The use of 5-HTP has been limited by an apparent small window between the occurrence of neuroendocrine endpoints and the occurrence of side effects. Therefore, many dosing strategies have been tried with and without concurrent administration of carbidopa, a peripheral inhibitor of the decarboxylation from 5-HTP to serotonin. Link: ./index.php?lvl=notice_display&id=31084

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder / Joseph Zohar en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 190-195 Título : Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder Tipo de documento: texto impreso Autores: Joseph Zohar, Autor ; Daniela Amital, Autor ; Chanoch Miodownik, Autor Fecha de publicación: 2023 Artículo en la página: pp. 190-195 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastornos de combate, Sertralina. Resumen: The efficacy of sertraline in the treatment of civilian posttraumatic stress disorder (PTSD) has been established by two large placebo-controlled trials. The purpose of the current pilot study was to obtain preliminary evidence of the efficacy of sertraline in military veterans suffering from PTSD. Link: ./index.php?lvl=notice_display&id=31085 [artículo] Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder [texto impreso] / Joseph Zohar, Autor ; Daniela Amital, Autor ; Chanoch Miodownik, Autor . - 2023 . - pp. 190-195. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 190-195 Palabras clave: Antidepresivos, Trastornos de combate, Sertralina. Resumen: The efficacy of sertraline in the treatment of civilian posttraumatic stress disorder (PTSD) has been established by two large placebo-controlled trials. The purpose of the current pilot study was to obtain preliminary evidence of the efficacy of sertraline in military veterans suffering from PTSD. Link: ./index.php?lvl=notice_display&id=31085